SWOG clinical trial number
SWOG-8278

FUVAC with Intensive Consolidation for ER-Negative Metastatic Breast Cance

Closed
Phase
Published
Abbreviated Title
FUVAC with Intensive Consolidation for ER-Negative Metastatic Breast Cance
Activated
06/27/1985
Closed
09/27/1985

Publication Information Expand/Collapse

1987

Short-term chemotherapy of poor-prognosis metastatic breastcancer with three non-cross resistant chemotherapy regimens: ASouthwest Oncology Group study.

FR Ahmann;R Pugh Cancer 59(2):239-244

Combination chemotherapy and systemic irradiation consolidation for poor prognosis breast cancer.

RB Livingston;S Schulman;BR Griffin;BL Tranum;SE Rivkin;RS Goldberg;CJ Fabian;N Hammond;H Hynes Cancer 59:1249-1254

1986

Sequential hemibody irradiation (HBI) or cyclophosphamide (CTX) + total body irradiation (RBI) + autologous bone marrow infusion (ABM) as consolidation for estrogen receptor, negative, disseminated breast cancer. A Southwest Oncology Group Study.

R. Livingston;B Griffin;S Schulman AACR 27:205(#812)

1985

Short term treatment of poor prognosis metastatic breast cancer with three alternating chemotherapy regimens: A Southwest Oncology Group pilot study.

FR Ahmann;R Pugh ASCO, #C-264